Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Prevalence of HCV Among Baby Boomers in US

J Infect Public Health; ePub 2018 Aug 28; Moore, et al

Baby boomers (BB) had the highest prevalence of hepatitis C virus (HCV) infection among the US population, and it’s important for healthcare professionals to identify age-specific risk factors in this group and use them in targeted screening and public health prevention efforts. This according to a recent study that examined US adult HCV prevalence and age-specific risk factors for chronic HCV infection. Researchers analyzed data from the National Health and Nutrition Examination Survey (NHANES) from 1999-2012. Age was divided into 3 categories: BB, younger than BB (YG), and older than BB (OG). They found:

  • Overall prevalence of chronic HCV was 1.19% with a US population estimate of 2,347,852 US adults.
  • BB had the highest prevalence at 2.23%, accounting for >74% of all chronic HCV cases.
  • HCV prevalence was highest among all ages (1.83%) and BB (2.71%) in 2001-2002.
  • Among BB, males, non-Hispanic blacks, having positive blood transfusion history, current and former smokers, and living below the poverty level were significant predictors of chronic HCV positivity.


Moore KJ, Gauri A, Koru-Sengul T. Prevalence and sociodemographic disparities of hepatitis C in Baby Boomers and the US adult population. [Published online ahead of print August 28, 2018]. J Infect Public Health. doi:10.1016/j.jiph.2018.08.003.

This Week's Must Reads

CVD Events Prevented with New AHA BP Guideline, Circulation; ePub 2018 Nov 19; Bress, et al

USPSTF: Interventions to Prevent Child Maltreatment, JAMA; 2018 Nov 27; US Preventive Services Task Force

Team-Based Primary Care in Chronically Ill Patients, JAMA Intern Med; ePub 2018 Nov 26; Meyers, et al

Rotating Night Shift Work & Risk of T2D, BMJ; ePub 2018 Nov 21; Shan, Li, et al

PUFAs for Primary & Secondary CVD Prevention, Cochrane Library; ePub 2018 Nov 27; Abdelhamid, et al

Must Reads in Hepatitis

Glecaprevir/Pibrentasvir in HCV GT 3 Infection, J Viral Hepat; ePub 2018 Nov 12; Flamm, et al

HCV Therapy Reduces CVD Events in Veterans, Gastroenterology; ePub 2018 Nov 13; Butt, et al

Alcohol Use Disorder in Patients with HCV/HIV , Drug Alcohol Depend; 2018 Oct 30; Frost, et al

Sexually-acquired HCV in MSM Using PrEP, J Infect Dis; ePub 2018 Nov 20; Price, et al

Effective HCV Testing In US Prisons, Am J Prev Med; ePub 2018 Nov 19; Assoumou, et al